LHFPL tetraspan subfamily member 7, designated as LHFPL7, belongs to the LHFPL family of proteins, which are characterized by their four hydrophobic transmembrane domains, making them part of the broader class of tetraspan transmembrane proteins. The LHFPL7 protein is encoded by the LHFPL7 gene located on chromosome 19 in humans.While detailed functional insights of LHFPL7 are not as extensively documented as those of some other tetraspan proteins, members of this family are generally implicated in a variety of cellular processes. These processes typically involve the modulation of cell signaling, trafficking of other membrane proteins, and contributing to the structure and maintenance of various cellular membranes.
LHFPL7, like its family members, is thought to play a role in the formation of complexes at cell membranes that are crucial for cell-to-cell communication and signal transduction. The tetraspan nature of LHFPL7 suggests a functional involvement in organizing the architecture of membrane domains, potentially influencing the assembly of signaling complexes or acting as scaffolds for receptor stabilization.Given the structural characteristics of tetraspanins, LHFPL7 may participate in the clustering of specific sets of proteins, such as receptors or ion channels, thereby influencing their functional properties. This could affect processes such as synaptic transmission or sensory perception, where precise membrane protein organization is critical.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
This compound inhibits protein synthesis in eukaryotic organisms, potentially reducing LHFPL7 protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in protein synthesis and cell growth, which may decrease LHFPL7. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
By binding to DNA, Actinomycin D inhibits RNA synthesis, which could lead to reduced LHFPL7 mRNA transcription. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A kinase inhibitor that may downregulate signaling pathways involved in LHFPL7 expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
An antitumor antibiotic that can crosslink DNA, potentially decreasing LHFPL7 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
A pyrimidine analog that disrupts RNA processing and function, possibly reducing LHFPL7 expression. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
By inhibiting EGFR tyrosine kinase, Gefitinib may impact signaling pathways regulating LHFPL7 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
TSA is an HDAC inhibitor that can alter gene expression, potentially affecting LHFPL7 levels. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
This compound inhibits RNA polymerase II and could decrease LHFPL7 mRNA synthesis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that may affect protein turnover, indirectly impacting LHFPL7 stability. | ||||||